Oak Thistle LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,940 shares of the company's stock, valued at approximately $681,000.
Other institutional investors have also added to or reduced their stakes in the company. Investment Management Corp VA ADV bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $32,000. Rakuten Securities Inc. bought a new position in Henry Schein in the 1st quarter worth approximately $34,000. Whittier Trust Co. boosted its holdings in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after buying an additional 700 shares during the period. UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after buying an additional 201 shares during the period. Finally, Allworth Financial LP boosted its holdings in Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after buying an additional 232 shares during the period. 96.62% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
HSIC has been the subject of several analyst reports. Wells Fargo & Company lowered their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Stifel Nicolaus restated a "hold" rating and set a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Barrington Research lowered their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Finally, Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Henry Schein presently has an average rating of "Hold" and a consensus price target of $78.08.
View Our Latest Stock Analysis on Henry Schein
Henry Schein Stock Down 0.5%
Shares of NASDAQ HSIC traded down $0.39 during midday trading on Monday, hitting $71.07. The stock had a trading volume of 567,891 shares, compared to its average volume of 1,714,078. The business's 50 day moving average is $71.90 and its 200-day moving average is $71.39. The company has a market cap of $8.65 billion, a P/E ratio of 22.21, a PEG ratio of 2.31 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the company earned $1.10 earnings per share. The firm's quarterly revenue was down .1% on a year-over-year basis. As a group, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.